Sofregen Medical
Sofregen
Cambridge, United States · Founded 2015
- Headquarters
- Cambridge
- Founded
- 2015
- Business Model
- B2B
- Website
- sofregen.com
- Last Round
- SeedSep 2016
- Rounds
- 3
About
Sofregen is a biomaterials company that grew out of silk protein research at Tufts University's Biomedical Engineering Department, developing a highly purified silk protein platform for regenerative medicine. Its FDA-cleared products include the SERI Surgical Scaffold (cleared 2013, acquired by Sofregen in 2016) and the Silk Voice injectable implant (cleared 2019) for vocal fold medialization, both designed to support tissue regeneration in aesthetic and reconstructive surgical procedures.
Summary
Sofregen Medical is a Biotech company based in Cambridge, United States, founded in 2015. Its most recent funding was a Seed round in Sep 2016. Investors include Polaris Partners.
Funding History
Sep 2016
Sign up to see all 4 rounds
Debt Financing through Series A — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Altos Labs combines academic science and industry development to create medicines that restore ce...
Specialty pharmaceutical company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/sofregen-medical"><img src="https://indexed.vc/api/badge/company/sofregen-medical" alt="Sofregen Medical on Indexed.vc" width="260" height="76" /></a>